Advances in Early Diagnostic Markers for Hepatocellular Liver Cancer

Hepatocellular carcinoma (HCC) is a common malignancy in China, and its incidence and lethality are increasing every year, so it is especially important to choose cost-effective diagnostic methods to achieve early diagnosis and treatment. At present, the most widely used examination measures in the world are ultrasonography of the liver and tumor marker alpha-fetoprotein (AFP), but its accuracy is limited, the research on tumor markers of HCC has been progressing rapidly in recent years, and this paper summarizes the roles and values of protein markers, enzyme and its isozymes markers, and gene markers in the identification of early hepatocellular carcinoma.